Clinical Trial Update: Clinical Trial on Agitation in Alzheimer's Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating agitation in Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: IGC Pharma, LLC | Conditions: Alzheimer Disease, Agitation,Psychomotor | Phase 2 | Status: RECRUITING